Similar articles for PMID: 16973389

Year	Number of Results
1978	1
1984	1
1985	1
1990	2
1994	1
1997	1
1999	2
2000	1
2003	2
2004	4
2005	13
2006	26
2007	19
2008	17
2009	15
2010	18
2011	14
2012	13
2013	14
2014	14
2015	21
2016	16
2017	11
2018	16
2019	9
2020	5
2021	8
2022	10
2023	3
2024	0

1

Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.

Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Christensen SR, et al. Immunity. 2006 Sep;25(3):417-28. doi: 10.1016/j.immuni.2006.07.013. Immunity. 2006. PMID: 16973389 Free article.

2

Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.

Santiago-Raber ML, Dunand-Sauthier I, Wu T, Li QZ, Uematsu S, Akira S, Reith W, Mohan C, Kotzin BL, Izui S. Santiago-Raber ML, et al. J Autoimmun. 2010 Jun;34(4):339-48. doi: 10.1016/j.jaut.2009.11.001. Epub 2009 Nov 26. J Autoimmun. 2010. PMID: 19944565

3

Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.

Yu P, Wellmann U, Kunder S, Quintanilla-Martinez L, Jennen L, Dear N, Amann K, Bauer S, Winkler TH, Wagner H. Yu P, et al. Int Immunol. 2006 Aug;18(8):1211-9. doi: 10.1093/intimm/dxl067. Epub 2006 Jun 23. Int Immunol. 2006. PMID: 16798839

4

Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.

Barrat FJ, Meeker T, Chan JH, Guiducci C, Coffman RL. Barrat FJ, et al. Eur J Immunol. 2007 Dec;37(12):3582-6. doi: 10.1002/eji.200737815. Eur J Immunol. 2007. PMID: 18034431 Free article.

5

Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.

Lartigue A, Colliou N, Calbo S, François A, Jacquot S, Arnoult C, Tron F, Gilbert D, Musette P. Lartigue A, et al. J Immunol. 2009 Nov 15;183(10):6207-16. doi: 10.4049/jimmunol.0803219. Epub 2009 Oct 19. J Immunol. 2009. PMID: 19841185

6

Toll-like receptor 9 signaling protects against murine lupus.

Wu X, Peng SL. Wu X, et al. Arthritis Rheum. 2006 Jan;54(1):336-42. doi: 10.1002/art.21553. Arthritis Rheum. 2006. PMID: 16385525 Free article.

7

Emerging roles of TLR7 and TLR9 in murine SLE.

Santiago-Raber ML, Baudino L, Izui S. Santiago-Raber ML, et al. J Autoimmun. 2009 Nov-Dec;33(3-4):231-8. doi: 10.1016/j.jaut.2009.10.001. Epub 2009 Oct 21. J Autoimmun. 2009. PMID: 19846276 Review.

8

TLR7/9-mediated monocytosis and maturation of Gr-1(hi) inflammatory monocytes towards Gr-1(lo) resting monocytes implicated in murine lupus.

Santiago-Raber ML, Baudino L, Alvarez M, van Rooijen N, Nimmerjahn F, Izui S. Santiago-Raber ML, et al. J Autoimmun. 2011 Nov;37(3):171-9. doi: 10.1016/j.jaut.2011.05.015. Epub 2011 Jun 12. J Autoimmun. 2011. PMID: 21665436

9

Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.

Kobayashi T, Takahashi K, Nagai Y, Shibata T, Otani M, Izui S, Akira S, Gotoh Y, Kiyono H, Miyake K. Kobayashi T, et al. Int Immunol. 2008 Jul;20(7):881-91. doi: 10.1093/intimm/dxn049. Epub 2008 May 19. Int Immunol. 2008. PMID: 18492657

10

Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.

Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, Chang B, Duramad O, Coffman RL. Barrat FJ, et al. J Exp Med. 2005 Oct 17;202(8):1131-9. doi: 10.1084/jem.20050914. J Exp Med. 2005. PMID: 16230478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

254 results

Results by year